World’s Largest Cancer App Now Includes Chronic Myeloid Leukemia Community

A HOLD FreeRelease 1 | eTurboNews | eTN
Avatar of Linda Hohnholz
Written by Linda Hohnholz

Belong.Life, a developer of social and professional networks for managing and navigating various diseases and patient journeys, announced today the launch of a dedicated community for chronic myeloid leukemia (CML) patients on its Belong-Beating Cancer Together app.

Chronic myeloid leukemia, also known as chronic myelogenous leukemia, is a slow-progressing cancer that originates in the bone marrow, typically affecting older adults. With CML comprising about 15% of new leukemia diagnoses in the U.S., Belong.Life received numerous requests from patients and caregivers to create a community specific to this disease. The new community will feature a designated folder with updated educational content customized to CML patients and caregivers.

“We are proud to launch this vital community,” said Dr. Daniel Vorobiof, Chief Medical Director of Belong.Life. “Our aim is to provide the largest engagement and education network for CML patients and caregivers in the United States. Our customized CML tool, in conjunction with our proven personalized platform with strong AI and real-world research capabilities, will enhance engagement and real-life treatment journeys for our users.”

Belong’s platforms include support groups, access to medical professionals and additional navigation tools, such as a medical binder to store and organize medical records in one place, as well as a free clinical trial matching service. The Beating Cancer Together community will have two main groups – CML General and CML Symptoms and Side Effects.

To further improve patients’ quality of life, Belong has integrated a CML Tracker, an innovative tool that allows patients to keep track of their symptoms over the course of their disease and treatment. All CML users will also have access to Belong-Beating Cancer Together’s general groups, such as Cancer & Coronavirus, Find Clinical Trials, Sexuality & Cancer, Insurance and many more.

Belong’s CML community group will be facilitated by Mel Mann, 26-year CML survivor, patient advocate and consultant. Mel was diagnosed with CML in 1994. Against all odds, Mel has been successfully managing his condition on targeted chemotherapy treatment since 1998 and will be sharing his experience, recommendations and tips with others going through the CML journey.

About the author

Avatar of Linda Hohnholz

Linda Hohnholz

Editor in chief for eTurboNews based in the eTN HQ.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x
Share to...